-
1
-
-
0025837793
-
Survival in patients withprimary pulmonary hypertension.Results from a national prospectiveregistry
-
D’AlonzoGE, BarstRJ, AyresSMet al(1991)Survival in patients withprimary pulmonary hypertension.Results from a national prospectiveregistry.Ann Intern Med115:343–349
-
(1991)
Ann Intern Med
, vol.115
, pp. 343-349
-
-
D’Alonzo, G.E.1
Barst, R.J.2
Ayres, S.M.3
-
2
-
-
0032578279
-
Primary pulmonary hypertension
-
GaineSP, RubinLJ(1998)Primary pulmonary hypertension. Lancet352:719–725
-
(1998)
Lancet
, vol.352
, pp. 719-725
-
-
Gaine, S.P.1
Rubin, L.J.2
-
3
-
-
0035989333
-
Pulmonary arterialhypertension and type-I glycogen-storage disease: The serotoninhypothesis
-
HumbertM, LabruneP, SitbonOet al(2002a)Pulmonary arterialhypertension and type-I glycogen-storage disease: the serotoninhypothesis. EurRespir J20:59–65
-
(2002)
Eurrespir J
, vol.20
, pp. 59-65
-
-
Humbert, M.1
Labrune, P.2
Sitbon, O.3
-
4
-
-
0036390115
-
Severe pulmonaryarterial hypertension in type 1 glycogen storage disease
-
HumbertM, LabruneP, SimonneauG(2002b)Severe pulmonaryarterial hypertension in type 1 glycogen storage disease. Eur JPediatr161(Suppl 1):S93–S96
-
(2002)
Eur Jpediatr
, vol.161
, pp. S93-S96
-
-
Humbert, M.1
Labrune, P.2
Simonneau, G.3
-
5
-
-
33646269035
-
Pulmonary arterialhypertension in France: Results from a national registry
-
HumbertM, SitbonO, ChaouatAet al(2006)Pulmonary arterialhypertension in France: results from a national registry. Am J RespirCrit Care Med173:1023–1030
-
(2006)
Am J Respircrit Care Med
, vol.173
, pp. 1023-1030
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
-
6
-
-
77955155274
-
Glycogen storage diseasetype III diagnosis and management guidelines
-
KishnaniPS, AustinSL, ArnPet al(2010)Glycogen storage diseasetype III diagnosis and management guidelines. Genet Med12(7):446–463
-
(2010)
Genet Med
, vol.12
, Issue.7
, pp. 446-463
-
-
Kishnani, P.S.1
Austin, S.L.2
Arn, P.3
-
7
-
-
0029998632
-
Mediators, cytokines, and growth factors inliver-lung interactions
-
PanosRJ, BakerSK(1996)Mediators, cytokines, and growth factors inliver-lung interactions.Clin Chest Med17:151–169
-
(1996)
Clin Chest Med
, vol.17
, pp. 151-169
-
-
Panos, R.J.1
Baker, S.K.2
-
8
-
-
0018819647
-
Type I glycogen storage disease with focal nodularhyperplasia of the liver and vasoconstrictive pulmonary hypertension
-
PizzoCJ(1980)Type I glycogen storage disease with focal nodularhyperplasia of the liver and vasoconstrictive pulmonary hypertension.Pediatrics65:341–343
-
(1980)
Pediatrics
, vol.65
, pp. 341-343
-
-
Pizzo, C.J.1
-
9
-
-
33749250737
-
Glycogen storage disease: Clinical, biochemical, andmolecular heterogeneity
-
ShinYS(2006)Glycogen storage disease: clinical, biochemical, andmolecular heterogeneity. SeminPediatrNeurol13:115–120
-
(2006)
Seminpediatrneurol
, vol.13
, pp. 115-120
-
-
Shin, Y.S.1
-
10
-
-
0020080838
-
Reversal of debrancherdeficiency myopathy by the use of high-protein nutrition
-
SlonimAE, WeisbergC, BenkePet al(1982)Reversal of debrancherdeficiency myopathy by the use of high-protein nutrition. AnnNeurol11:420–422
-
(1982)
Annneurol
, vol.11
, pp. 420-422
-
-
Slonim, A.E.1
Weisberg, C.2
Benke, P.3
-
11
-
-
76749128460
-
Advances in diagnosisand treatment of pulmonary arterial hypertension in neonates andchildren with congenital heart disease
-
SuesaowalakM, ClearyJP, ChangAC(2010)Advances in diagnosisand treatment of pulmonary arterial hypertension in neonates andchildren with congenital heart disease. World J Pediatr6:13–31
-
(2010)
World J Pediatr
, vol.6
, pp. 13-31
-
-
Suesaowalak, M.1
Cleary, J.P.2
Chang, A.C.3
|